Zpráva o průběhu klinického hodnocení MSC-EB 12. října 2022 ‒ 11. října 2023

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	MSC-EB Clinical Trial Progress Report October 12, 2022 - October 11, 2023
Authors	DEMLOVÁ Regina KUBÁTOVÁ Jana
Year of publication	2023
MU Faculty or unit	Faculty of Medicine
Web	MSC-EB
Description	The annual report gives the overview of the conduct of the clinical trial „Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells in Patients with Epidermolysis Bullosa: Clinical Trial Phase I/II“. The primary aim of the clinical trial is to study the safety of innovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:	CZECRIN - Czech National Node to the European Clinical Research Infrastructure Network